Shanghai Yizhong Pharmaceutical Co., Ltd. (SHA:688091)
China flag China · Delayed Price · Currency is CNY
51.55
-1.76 (-3.30%)
Feb 24, 2026, 3:00 PM CST

SHA:688091 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
317.08173.03359.75235.74.08
Other Revenue
-0.510.510.25-
317.08173.53360.25235.964.08
Revenue Growth (YoY)
82.72%-51.83%52.68%5686.76%-
Cost of Revenue
-13.3423.6216.970.3
Gross Profit
317.08160.2336.63218.993.78
Selling, General & Admin
-143.05147.5798.6417.29
Research & Development
-37.222.457.9313.24
Other Operating Expenses
2551.011.610.90.03
Operating Expenses
255176.21177.07109.5130.77
Operating Income
62.08-16.01159.57109.48-26.99
Interest Expense
--0.7-0.27--0.59
Interest & Investment Income
-25.0434.3530.328.6
Other Non Operating Income (Expenses)
-1.12-0.09-0.05-0-0.02
EBT Excluding Unusual Items
60.968.24193.59139.79-19
Gain (Loss) on Sale of Investments
--0.420.93.25
Gain (Loss) on Sale of Assets
--0---
Other Unusual Items
--3.42-7.118.876.47
Pretax Income
60.964.82186.9149.56-9.28
Income Tax Expense
-3.17-2.1625.356.71-5.28
Net Income
64.136.98161.55142.85-4
Net Income to Common
64.136.98161.55142.85-4
Net Income Growth
819.42%-95.68%13.09%--
Shares Outstanding (Basic)
207233158206156
Shares Outstanding (Diluted)
207233158206156
Shares Change (YoY)
-11.02%46.80%-23.24%32.68%2.51%
EPS (Basic)
0.310.031.020.69-0.03
EPS (Diluted)
0.310.031.020.69-0.03
EPS Growth
933.33%-97.06%47.34%--
Free Cash Flow
--40.677.7774.9-51.93
Free Cash Flow Per Share
--0.170.490.36-0.33
Dividend Per Share
--0.0310.210-
Dividend Growth
---85.22%--
Gross Margin
100.00%92.31%93.44%92.81%92.75%
Operating Margin
19.58%-9.23%44.29%46.40%-661.96%
Profit Margin
20.23%4.02%44.84%60.54%-98.03%
Free Cash Flow Margin
--23.40%21.59%31.74%-1273.49%
EBITDA
73.24-4.85167.45115.91-20.4
EBITDA Margin
23.10%-2.79%46.48%49.12%-
D&A For EBITDA
11.1611.167.886.436.59
EBIT
62.08-16.01159.57109.48-26.99
EBIT Margin
19.58%-9.23%44.29%46.40%-
Effective Tax Rate
--13.56%4.48%-
Revenue as Reported
-173.53360.25235.964.08
Advertising Expenses
----0.33
Source: S&P Global Market Intelligence. Standard template. Financial Sources.